Tomas Rokos

Tomas Rokos


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
EKErik Kudela
Erik Kudela
TRTomas Rokos
Tomas Rokos
EKErik Kozubík
Erik Kozubík
TPTerezia Pribulova
Terezia Pribulova
FPFilip Piovar
Filip Piovar
KBKamil Biringer
Kamil Biringer
Multiple high-risk human papillomavirus (hrHPV) infections in young women are poorly characterized across age and cytology, particularly with partial genotyping. We assessed multiple hrHPV infections among HPV-positive women aged 18–25 years with NILM, ASC-US, or LSIL; the secondary objective was hrHPV positivity among electively tested women with NILM. This retrospective cross-sectional study analyzed 2024 laboratory data from northern Slovakia. Of 7613 unique women, 7574 met cytological eligibility criteria; 804 underwent cobas 4800 testing, and 295 were hrHPV-positive. Multiple infection, defined as concurrent detection of at least two reportable categories (HPV16, HPV18, or other hrHPV), occurred in 69/295 women (23.4%; 95% CI, 18.9–28.5%). No statistically detectable variation was observed by cytology after age adjustment (p = 0.471) or by age after cytology adjustment (p = 0.891). Among women with multiple infections, HPV16 combined with other hrHPV was the most frequent pattern (30/69; 43.5%). Among 396 electively tested women with NILM, 75 were hrHPV-positive (18.9%; 95% CI, 15.4–23.1%); positivity was lower at ages 23–25 than 18–22 (10.6% vs. 26.6%; OR, 0.33; 95% CI, 0.19–0.57; p < 0.001). The NILM estimate describes a self-selected preventive cohort and is not population-representative.